$1.380
-0.048 (-3.50%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
INM 相似图表分析预测
Alphio's INM stock price prediction model matches the current InMed Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.36 (-1.29%). The 1-week path is $1.37 (-0.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 InMed Pharmaceuticals Inc 股票吗？
InMed Pharmaceuticals is not a good buy right now due to its low RSI of 31.092, indicating oversold conditions, and a significant 1-year change of -36.11%. While the recent merger news may provide some potential upside, the current financial performance shows a troubling trend with a net income loss of -2,966,336 USD in Q3 2026 and a gross margin drop to 15.97% in Q2 2026, which raises concerns about its profitability and sustainability.
INM 股价于 Friday 收于 $1.38，此前下跌 -3.50%
InMed Pharmaceuticals Inc (INM) last closed at $1.38, losing -3.50%. These facts feed the 1-day and 1-week INM price prediction above.
预测驱动因素
InMed Pharmaceuticals Inc（INM）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
相似图表形态
近期走势与 INM 最接近的股票，按相似度排序。
INM 季节性分析
Historically the probability of a positive August return for INM is 39.68%. August offers the highest probability of a positive month at 39.68%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。